COMPANY PROFILE / #1575
Aillis
Tokyo, JapanVenture Capital-Backed
OVERVIEW
Developer of an artificial intelligence-equipped pharyngoscopy system designed to diagnose infectious diseases from pharyngeal photographs. The company's platform utilizes a specialized camera to capture images of the pharynx and applies AI technology to analyze the images for signs of infection, enabling healthcare providers to diagnose illnesses efficiently and accurately.
已融资54.57
最新估值125.15
员工数100
成立年份2017
公司概况
- Companies
- Aillis
- Description
- Developer of an artificial intelligence-equipped pharyngoscopy system designed to diagnose infectious diseases from pharyngeal photographs. The company's platform utilizes a specialized camera to capture images of the pharynx and applies AI technology to analyze the images for signs of infection, enabling healthcare providers to diagnose illnesses efficiently and accurately.
- Website
- www.aillis.jp
- HQ Location
- Tokyo, Japan
- Year Founded
- 2017
- Keywords
- ai device, influenza cure, influenza diagnostics, influenza test, influenza virus detection, medical device, medical equipment
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 54.57
- First Financing Date
- —
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 04-Apr-2025
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 13.43
- Last Financing Valuation
- 125.15
- Last Financing Status
- Completed
- Last Known Valuation
- 125.15
- Last Known Valuation Date
- 04-Apr-2025
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 207.09
- Valuation Estimate Growth Rate
- 65.48%
- Active Investors
- Aozora Corporate Investment, Asahi Group Holdings, Beyond Next Ventures, Capital Medica Ventures, CEJ Capital, Cyberdyne (Therapeutic Devices), Hero Innovation Group, HiJoJo Partners, I-nest Capital, JP Life Next Fund, JSR Active Innovation Fund, J-Startup, LINK-J, Mirai Creation Capital, Mitsui Sumitomo Kaijo Capital, MTG Ventures, Nissay Capital, Pegasus Tech Ventures, Shionogi, SPARX Group Company, STRIVE (VC Investor), TAUNS Laboratories, Toda, Toranomon Impact Capital, Z Venture Capital
- # Active Investors
- 25
- Acquirers
- —
团队与联系人
- Employees
- 100
- Employee Growth %
- 51.52% E
- Employee History
- 2025: 100, 2024: 66 E, 2023: 31, 2022: 31, 2021: 33
- Primary Contact
- Sho Okiyama
- Primary Contact Title
- Co-Founder, Chief Executive Officer, President & Board Member
- Primary Contact Email
- sho.okiyama@aillis.jp
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- -0.07%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 13.54x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 95
- Majestic Referring Domains
- 352
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 5%
- Success Probability Over Time – 3 Year
- 18%
- Success Probability Over Time – 5 Year
- 28%
记录来源：public.companies · 原始序号 #1575 · 所有字段均按数据库原值展示。